RYOIX Stock: Rydex Biotechnology Fund Class Investor Stock Price, Analysis & Insights
Get live RYOIX stock price $78.62, comprehensive Rydex Biotechnology Fund Class Investor stock analysis, charts, news, and expert forecast. Real-time RYOIX stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
The Rydex Biotechnology Fund, Class Investor, aims to achieve capital growth for its shareholders. Under normal circumstances, the fund dedicates a significant majority – at least 80% – of its total net assets to common stocks of biotechnology enterp...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- 702 King Farm Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Lower volatility stock (Beta: 0.70) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Rydex Biotechnology Fund Class Investor shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Rydex Biotechnology Fund Class Investor
- ⚠Investors should consider how Rydex Biotechnology Fund Class Investor fits within their overall portfolio allocation
Market Cap
82.96M
Beta
0.70
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RYOIX with peer companies:
- Price
- $16.42
- Market cap
- 78.11M
- Price
- $14.02
- Market cap
- 72.70M
- Price
- $13.98
- Market cap
- 72.67M
- Price
- $20.69
- Market cap
- 85.96M
- Price
- $16.50
- Market cap
- 75.16M
- Price
- $16.69
- Market cap
- 75.12M
- Price
- $24.84
- Market cap
- 97.77M
- Price
- $953.96
- Market cap
- 183.80M
- Price
- $320.25
- Market cap
- 106.85M
- Price
- $29.01
- Market cap
- 92.43M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.